Kistler Tiffany Companies, LLC Novartis Ag Transaction History
Kistler Tiffany Companies, LLC
- $615 Million
- Q2 2023
A detailed history of Kistler Tiffany Companies, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 322 shares of NVS stock, worth $35,896. This represents 0.01% of its overall portfolio holdings.
Number of Shares
322
Previous 322
-0.0%
Holding current value
$35,896
Previous $29,000
10.34%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$912 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$766 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$622 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...